Annual Drug Patent Expirations for ONGENTYS
Ongentys is a drug marketed by Neurocrine and is included in one NDA. It is available from two suppliers. There are nine patents protecting this drug.
This drug has one hundred and thirteen patent family members in thirty-one countries.
The generic ingredient in ONGENTYS is opicapone. Two suppliers are listed for this compound. Additional details are available on the opicapone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
